| 7:30 am |
Registration and Breakfast |
| 8:00 am |
Welcome and Introductions
Anton Hagenbeek
|
| 8:05 am |
CD20 Monoclonal Antibodies: How They Work and How Tumors
Elude Them
Myron Czuczman |
| 8:20 am |
Challenges and New Directions With Antibody Therapy for B-Cell Non-Hodgkin Lymphoma
Bertrand Coiffier |
| 8:40 am |
Advances With CD20 Monoclonal Antibodies in the Treatment of Chronic Lymphocytic Leukemia
Stephan Stilgenbauer |
| 9:00 am |
Next-Generation Anti-CD20 Monoclonal Antibodies in B-Cell
Lymphomas
Anton Hagenbeek |
| 9:20 am |
Clinical Perspectives: A Case-Based Discussion of Novel CD20
Antibody Therapies for Chronic Lymphocytic Leukemia and
Non-Hodgkin Lymphoma
Moderator: Anton Hagenbeek
Panel: Bertrand Coiffier, Myron Czuczman, Anton Hagenbeek, and
Stephan Stilgenbauer |
| 9:55 am |
Concluding Remarks |
| 10:00 am |
Adjourn |
